Sort
51,593 grants matching “hepatitis”
Molecular Imaging of Liver Fibrosis
$527,284Kenneth K Tanabe · Massachusetts General Hospital · R01 · FY2019 · DK
PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCV
$527,244New York Blood Center · R01 · FY2003 · AI
Role of protein mediate fatty acid uptake in liver cancer
$527,212Andreas Stahl · University Of California Berkeley · R01 · FY2018 · CA
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
$527,165Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2019 · DK
Mechanisms of Hepatitis C Virus Evolution
$527,079Stuart C Ray · Johns Hopkins University · R01 · FY2011 · DA
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
$527,075Shruti H Mehta · Johns Hopkins University · T32 · FY2025 · AI
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
$527,068Amy Caroline Justice · Yale University · R01 · FY2017 · CA
Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II
$527,044Raymond L Ownby · Nova Southeastern University · R01 · FY2020 · MD
HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS
$526,999National Development &Res Institutes · R01 · FY2001 · DA
Lipid Nutrition and the Brain
$526,979Stanley I Rapoport · National Institute On Aging · Z01 · FY2008 · AG
Novel Therapies for Alcoholic Hepatitis
$526,938Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2017 · AA
Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
$526,925Wei Jia · University Of Hawaii At Manoa · U01 · FY2019 · CA
Etiology of Persistent Microalbuminuria in Nigeria
$526,922William Wester · Vanderbilt University Medical Center · R01 · FY2023 · DK
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI
$526,905Bachir Taouli · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DK
Novel Interferons and small molecule enhancers of the interferon pathway
$526,887Kenan Christopher Garcia · Stanford University · U19 · FY2017 · AI
Implementation of Seek, Test, Treat & Retain Strategies among People Who Inject Drugs in Malaysia
$526,815Marek C Chawarski · Yale University · R01 · FY2021 · DA
Trans-acting Factors Causing Cell Specific Gene Control
$526,809Kenneth S Zaret · University Of Pennsylvania · R37 · FY2013 · GM
CARBOXYFULLERENE TREATMENT OF MPTP-INDUCED PARKINSONISM
$526,785Joel Synes Perlmutter · Washington University · R01 · FY2009 · NS
Dysregulation of calcium signaling in the initiation of fatty liver disease
$526,782Paula Bartlett · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DK
The Role of Tcf7l2 in maintaining liver zonation and metabolic homeostasis
$526,737Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2025 · DK
Impact of HIV on Hepatitis C Infection in Hemophilia
$526,696University Of Pittsburgh At Pittsburgh · R01 · FY2001 · HL
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$526,622Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$526,622Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK
Phospholipid-Mediated Metabolic Control in the Liver
$526,618David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DK
Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entry
$526,610Ian Michael McGowan · University Of Louisville · U19 · FY2016 · AI